Phase 2 KRAS G12D Mutations Clinical Trials

2 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–2 of 2 trials

Recruiting

Phase 2

To Evaluate the Safety and Efficacy of RNK08954 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma.

Pancreatic Ductal Adenocarcinoma (PDAC)KRAS G12D Mutations

Ranok Therapeutics (Hangzhou) Co., Ltd.60 enrolled2 locationsNCT07303465

Recruiting

Phase 1Phase 2

A Study of GFH375 in Patients With Advanced Solid Tumors With KRAS G12D Mutations

Advanced Solid TumorsKRAS G12D Mutations

Genfleet Therapeutics (Shanghai) Inc.407 enrolled20 locationsNCT06500676